Adaptive licensing and facilitated regulatory pathways: A survey of stakeholder perceptions

Clin Pharmacol Ther. 2015 Nov;98(5):477-9. doi: 10.1002/cpt.140. Epub 2015 Jun 30.

Authors

L Liberti^{1

2}, P Stolk², N McAuslane¹, A Somauroo¹, A M Breckenridge³, H G M Leufkens²

Affiliations

¹ Centre for Innovation in Regulatory Science (CIRS), London, UK.
² Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.
³ Department of Pharmacology, School of Life Sciences, University of Liverpool, Liverpool, UK.

PMID: 25877216
DOI: 10.1002/cpt.140

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Drug Discovery / legislation & jurisprudence*
Drug Discovery / trends
Drug and Narcotic Control / legislation & jurisprudence*
Drug and Narcotic Control / trends
Humans
Licensure / legislation & jurisprudence*
Licensure / trends
Perception*
Surveys and Questionnaires*